Similar Papers

Paper Title
Journal
Date
Author
Abstract 956: Role of the cell cycle regulator LZTS1 in docetaxel resistance of prostate cancer cells and overcoming the docetaxel resistance by cell cycle pharmacological inhibitors.
Sophie Cotteret ... Karim Fizazi
Cancer Research | VOL. 73
Sophie Cotteret, et. al.Sophie Cotteret ... Karim Fizazi
15 Apr 2013
Differential gene screening and functional analysis in docetaxel-resistant prostate cancer cell lines*
Ming Wang ... Chaoqi Wang
Oncology and Translational Medicine | VOL. 8
Ming Wang, et. al.Ming Wang ... Chaoqi Wang
01 Apr 2022
Abstract 823: Integration of microRNA and gene expression signatures from several models of Docetaxel-resistant prostate cancer cell lines
Nicolas Martin ... Anne Chauchereau
Cancer Research | VOL. 72
Nicolas Martin, et. al.Nicolas Martin ... Anne Chauchereau
15 Apr 2012
LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
Xingkang Jiang ... Baojie Ma
Cellular Signalling | VOL. 65
Xingkang Jiang, et. al.Xingkang Jiang ... Baojie Ma
28 Oct 2019
View more papers

More From: European Urology

Paper Title
Journal
Date
Author
Editorial Board
-
European Urology | VOL. 87
--
01 Feb 2025
Platinum Hall of Fame
-
European Urology | VOL. 87
--
01 Feb 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma.
Jens Bedke ... Axel Bex
European urology | VOL. -
Jens Bedke, et. al.Jens Bedke ... Axel Bex
01 Feb 2025
Re: Characterizing Psychological Resources and Resilience in Patients with Bladder Cancer: Associations with Frailty and Quality of Life.
Rodolfo Hurle ... Massimo Lazzeri
European urology | VOL. -
Rodolfo Hurle, et. al.Rodolfo Hurle ... Massimo Lazzeri
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.